275 related articles for article (PubMed ID: 26921516)
1. Pharmaceutical strategies towards optimising polypharmacy in older people.
Hughes CM; Cadogan CA; Patton D; Ryan CA
Int J Pharm; 2016 Oct; 512(2):360-365. PubMed ID: 26921516
[TBL] [Abstract][Full Text] [Related]
2. Polypharmacy: the challenge for nurses.
Kaufman G
Nurs Stand; 2016 May; 30(39):52-60. PubMed ID: 27224631
[TBL] [Abstract][Full Text] [Related]
3. International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): Position Statement and 10 Recommendations for Action.
Mangin D; Bahat G; Golomb BA; Mallery LH; Moorhouse P; Onder G; Petrovic M; Garfinkel D
Drugs Aging; 2018 Jul; 35(7):575-587. PubMed ID: 30006810
[TBL] [Abstract][Full Text] [Related]
4. Guidance to manage inappropriate polypharmacy in older people: systematic review and future developments.
Stewart D; Mair A; Wilson M; Kardas P; Lewek P; Alonso A; McIntosh J; MacLure K;
Expert Opin Drug Saf; 2017 Feb; 16(2):203-213. PubMed ID: 27885844
[TBL] [Abstract][Full Text] [Related]
5. Rules for improving pharmacotherapy in older adult patients: part 1 (rules 1-5).
Wooten JM
South Med J; 2015 Feb; 108(2):97-104. PubMed ID: 25688894
[TBL] [Abstract][Full Text] [Related]
6. Measuring medication adherence in older community-dwelling patients with multimorbidity.
Kim S; Bennett K; Wallace E; Fahey T; Cahir C
Eur J Clin Pharmacol; 2018 Mar; 74(3):357-364. PubMed ID: 29199370
[TBL] [Abstract][Full Text] [Related]
7. Medication Appropriateness in Vulnerable Older Adults: Healthy Skepticism of Appropriate Polypharmacy.
Fried TR; Mecca MC
J Am Geriatr Soc; 2019 Jun; 67(6):1123-1127. PubMed ID: 30697698
[TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy in Older Adults with Cardiovascular Disease: Report from an American College of Cardiology, American Geriatrics Society, and National Institute on Aging Workshop.
Schwartz JB; Schmader KE; Hanlon JT; Abernethy DR; Gray S; Dunbar-Jacob J; Holmes HM; Murray MD; Roberts R; Joyner M; Peterson J; Lindeman D; Tai-Seale M; Downey L; Rich MW
J Am Geriatr Soc; 2019 Feb; 67(2):371-380. PubMed ID: 30536694
[TBL] [Abstract][Full Text] [Related]
9. Clinical medication reviews in elderly patients with polypharmacy: a cross-sectional study on drug-related problems in the Netherlands.
Chau SH; Jansen AP; van de Ven PM; Hoogland P; Elders PJ; Hugtenburg JG
Int J Clin Pharm; 2016 Feb; 38(1):46-53. PubMed ID: 26597955
[TBL] [Abstract][Full Text] [Related]
10. [Drug-related problems in the elderly].
Bor A; Matuz M; Doró P; Viola R; Soós G
Orv Hetil; 2012 Dec; 153(49):1926-36. PubMed ID: 23204299
[TBL] [Abstract][Full Text] [Related]
11. Adverse drug reactions in special populations - the elderly.
Davies EA; O'Mahony MS
Br J Clin Pharmacol; 2015 Oct; 80(4):796-807. PubMed ID: 25619317
[TBL] [Abstract][Full Text] [Related]
12. Assessing the Scope and Appropriateness of Prescribing Cascades.
McCarthy LM; Visentin JD; Rochon PA
J Am Geriatr Soc; 2019 May; 67(5):1023-1026. PubMed ID: 30747997
[TBL] [Abstract][Full Text] [Related]
13. Optimization of Drug Prescription and Medication Management in Older Adults with Cardiovascular Disease.
Wenger NK; Doherty CL; Gurwitz JH; Hirsch GA; Holmes HM; Maurer MS; Murray MD
Drugs Aging; 2017 Nov; 34(11):803-810. PubMed ID: 29110264
[TBL] [Abstract][Full Text] [Related]
14. Update on Medication Use Quality and Safety in Older Adults, 2017.
Gray SL; Marcum ZA; Schmader KE; Hanlon JT
J Am Geriatr Soc; 2018 Dec; 66(12):2254-2258. PubMed ID: 30423194
[TBL] [Abstract][Full Text] [Related]
15. [Not Available].
Heppner HJ
Drug Res (Stuttg); 2019 Nov; 69(S 01):S21-S22. PubMed ID: 31731307
[No Abstract] [Full Text] [Related]
16. Frailty, polypharmacy and deprescribing.
Drug Ther Bull; 2016 Jun; 54(6):69-72. PubMed ID: 27284125
[TBL] [Abstract][Full Text] [Related]
17. [Impact of Geriatric Drug Guidelines on the Quality Requirement of Elderly Patients].
Fauvelle F; Kabirian F; Domingues A; Tubach F; Gault N; Abbas R
Therapie; 2015; 70(6):515-21. PubMed ID: 26242496
[TBL] [Abstract][Full Text] [Related]
18. Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.
Tamargo J; Kjeldsen KP; Delpón E; Semb AG; Cerbai E; Dobrev D; Savarese G; Sulzgruber P; Rosano G; Borghi C; Wassmann S; Torp-Pedersen CT; Agewall S; Drexel H; Baumgartner I; Lewis B; Ceconi C; Kaski JC; Niessner A
Eur Heart J Cardiovasc Pharmacother; 2022 Jun; 8(4):406-419. PubMed ID: 35092425
[TBL] [Abstract][Full Text] [Related]
19. Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes.
Gnjidic D; Le Couteur DG; Kouladjian L; Hilmer SN
Clin Geriatr Med; 2012 May; 28(2):237-53. PubMed ID: 22500541
[TBL] [Abstract][Full Text] [Related]
20. Electronic prescribing and other forms of technology to reduce inappropriate medication use and polypharmacy in older people: a review of current evidence.
Clyne B; Bradley MC; Hughes C; Fahey T; Lapane KL
Clin Geriatr Med; 2012 May; 28(2):301-22. PubMed ID: 22500545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
